Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Magnetic Detection and Imaging Group, TechMed Centre, University of Twente, Enschede, The Netherlands.
Childs Nerv Syst. 2024 Sep;40(9):2697-2705. doi: 10.1007/s00381-024-06492-8. Epub 2024 Jun 11.
PURPOSE: The aim of this study was to evaluate the diagnostic value and accuracy of navigated intraoperative ultrasound (iUS) in pediatric oncological neurosurgery as compared to intraoperative magnetic resonance imaging (iMRI). METHODS: A total of 24 pediatric patients undergoing tumor debulking surgery with iUS, iMRI, and neuronavigation were included in this study. Prospective acquisition of iUS images was done at two time points during the surgical procedure: (1) before resection for tumor visualization and (2) after resection for residual tumor assessment. Dice similarity coefficients (DSC), Hausdorff distances 95th percentiles (HD95) and volume differences, sensitivity, and specificity were calculated for iUS segmentations as compared to iMRI. RESULTS: A high correlation (R = 0.99) was found for volume estimation as measured on iUS and iMRI before resection. A good spatial accuracy was demonstrated with a median DSC of 0.72 (IQR 0.14) and a median HD95 percentile of 4.98 mm (IQR 2.22 mm). The assessment after resection demonstrated a sensitivity of 100% and a specificity of 84.6% for residual tumor detection with navigated iUS. A moderate accuracy was observed with a median DSC of 0.58 (IQR 0.27) and a median HD95 of 5.84 mm (IQR 4.04 mm) for residual tumor volumes. CONCLUSION: We found that iUS measurements of tumor volume before resection correlate well with those obtained from preoperative MRI. The accuracy of residual tumor detection was reliable as compared to iMRI, indicating the suitability of iUS for directing the surgeon's attention to areas suspect for residual tumor. Therefore, iUS is considered as a valuable addition to the neurosurgical armamentarium. TRIAL REGISTRATION NUMBER AND DATE: PMCLAB2023.476, February 12th 2024.
目的:本研究旨在评估术中超声导航(iUS)在儿科肿瘤神经外科中的诊断价值和准确性,并与术中磁共振成像(iMRI)进行比较。
方法:本研究共纳入 24 名接受肿瘤切除术的儿科患者,术中采用 iUS、iMRI 和神经导航。在手术过程中,前瞻性地采集 iUS 图像,共两个时间点:(1)切除前用于肿瘤可视化,(2)切除后用于评估残留肿瘤。计算 iUS 分割与 iMRI 之间的 Dice 相似系数(DSC)、Hausdorff 距离 95%分位数(HD95)和体积差异、灵敏度和特异性。
结果:术前切除前,iUS 和 iMRI 测量的体积估计具有高度相关性(R=0.99)。良好的空间准确性显示,中位数 DSC 为 0.72(IQR 0.14),中位数 HD95 分位数为 4.98mm(IQR 2.22mm)。切除后评估显示,导航 iUS 检测残留肿瘤的灵敏度为 100%,特异性为 84.6%。残留肿瘤体积的中位数 DSC 为 0.58(IQR 0.27),中位数 HD95 为 5.84mm(IQR 4.04mm),准确性中等。
结论:我们发现,术前切除前 iUS 测量的肿瘤体积与术前 MRI 获得的体积具有良好的相关性。与 iMRI 相比,残留肿瘤检测的准确性可靠,表明 iUS 适合引导外科医生注意怀疑有残留肿瘤的区域。因此,iUS 被认为是神经外科武器库中的一项有价值的补充。
试验注册号和日期:PMCLAB2023.476,2024 年 2 月 12 日。
Childs Nerv Syst. 2024-9
Oper Neurosurg (Hagerstown). 2025-2-1
Childs Nerv Syst. 2015-12
Front Neurosci. 2022-4-19
Neurosurg Rev. 2022-8
World Neurosurg. 2022-1
Front Oncol. 2021-8-18
Medicine (Baltimore). 2021-6-25